Pathogenica, Inc. Information

Pathogenica specializes in ultra-­precise, information­‐rich diagnostic methods that utilize the speed and economy of next­‐generation DNA sequencing for use in labs, hospitals, and clinics. Pathogenica’s high throughput pathogen detection technology delivers rapid and highly sensitive identification of a wide variety of pathogens from a patient sample. The core technologies are backed by solid intellectual property, which includes inventions from Harvard and Stanford and the company has already begun selling its first commercial product, a broad panel test kit for hospital­‐acquired infections (HAI). Pathogenica, Inc. is a privately held company, founded in July 2009 in Cambridge, Massachusetts. The founding scientific advisory board (SAB) is comprised of distinguished scientists in the field, including George Church, Harvard Medical School, Ronald Davis, Stanford University, W.Ian Lipkin, Columbia University, Andrew Onderdonk, Harvard Medical School and Kun Zhang, University of California.